ARCHIVES

Study Tests PARP Inhibitor ABT-888 For Several Cancers

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

Correction: Appropriations Reports Included Language of Minorities and Underserved

October 15, 1999

NCI prepares for third hearing on conflicts of interest.

June 18, 2004

AMC Cancer Center, Rose Cancer Program Name Douglass Tormey Director; ECG Plans Move To Denver

September 4, 1992

NIH Clinical Trials Committee Adopts Recommendations For Safety Monitoring

June 22, 1979

FDA Grants Orphan Designation To Photofrin for Mesothelioma

December 30, 2011

FDA Nearly Wrecks NCI Drug Distribution Program, Finally Agrees To New Guidelines

January 30, 1976